03 September 2021 : Clinical Research
Genital Human Papillomavirus Prevalence and Genotyping Among Males in Putuo District of Shanghai, China 2015-2019
Xiaoxiao Li1ACDEG*, Fenfen Xiang1C, Zixi Chen1D, Tao Zhang1B, Zhaowei Zhu1BC, Mengzhe Zhang1BF, Rong Wu1DG, Xiangdong Kang1ADOI: 10.12659/MSM.932093
Med Sci Monit 2021; 27:e932093
Table 5 Prevalence by human papillomavirus type in male patients by age groups over 5 years.
| Age (years) | Men, No. | 2vHPV* | 4vHPV** | 9vHPV*** |
|---|---|---|---|---|
| Overall | 1227 | 94 (7.66%) | 690 (56.23%) | 726 (59.17%) |
| ≤24 | 164 | 20 (12.20%) | 105 (64.02%) | 108 (65.85%) |
| 25–34 | 498 | 46 (9.24%) | 260 (52.21%) | 266 (53.41%) |
| 35–44 | 252 | 15 (5.95%) | 122 (48.41%) | 125 (49.60%) |
| 45–54 | 132 | 5 (3.79%) | 80 (60.61%) | 104 (78.79%) |
| ≥55 | 181 | 8 (4.42%) | 123 (67.96%) | 123 (67.96%) |
| * 2vHPV – includes HPV-16 and -18; ** 4vHPV – includes HPV-6, -11, -16, and -18; *** 9vHPV – includes HPV-6, -11, -16, -18, -31, -33, -45, -52, and -58. | ||||